Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis

Michael Horckmans, Esteban Diaz Villamil, Céline Verdier, Henrik Laurell, H., Jean-Bernard Ruidavets, Lucas De Roeck, Guillaume Combes, Laurent O. Martinez and Didier Communi. Frontiers in Pharmacology (2022) https://doi.org/10.3389/fphar.2022.1049696

Previous
Previous

Thyroid-on-a-chip: An Organoid Platform For In Vitro Assessment of Endocrine Disruption

Next
Next

Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss